
Merit Medical Systems (MMSI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Merit Medical Systems (MMSI) last issued guidance on July 30, 2026 for fiscal year 2026. The company guided earnings per share in the range of $4.25 - $4.35, compared to a consensus EPS estimate of $3.98. Merit Medical Systems also guided revenue in the range of $1.63B - $1.64B for the period.
Compared to prior guidance, Merit Medical Systems raised its EPS outlook from a previous range of $4.01 - $4.15. On the revenue side, the company maintained its revenue forecast from a prior range of $1.61B - $1.63B.
Merit Medical Systems has issued 24 guidance updates between October 26, 2022 and July 30, 2026. During this period, the company raised its outlook 11 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.94 | $0.81 | $0.91 | $0.79 |
| Actual | $1.19 | $0.94 | $1.04 | $0.92 |
| Surprise | +26.6% | +16.1% | +14.3% | +16.5% |
| Revenue | ||||
| Estimate | $405.2M | $377.5M | $390.9M | $371.5M |
| Actual | $418.8M | $381.9M | $393.9M | $384.2M |
| Surprise | +3.36% | +1.16% | +0.78% | +3.40% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.01 | $1.11 | $0.89 | $1.07 |
| Revenue | ||||
| Consensus | $410.4M | $424.7M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $1.19 | $0.94 | 26.6 % |
| Q1 | Apr 30, 2026 | $0.94 | $0.81 | 16.1 % |
| Q4 | Feb 24, 2026 | $1.04 | $0.91 | 14.3 % |
| Q3 | Oct 30, 2025 | $0.92 | $0.79 | 16.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $418.84M | $405.22M | 3.36 % |
| Q1 | Apr 30, 2026 | $381.88M | $377.49M | 1.16 % |
| Q4 | Feb 24, 2026 | $393.94M | $390.88M | 0.78 % |
| Q3 | Oct 30, 2025 | $384.16M | $371.53M | 3.40 % |